-
The global cumulative number of confirmed cases of new crown reached 188,128,952
Time of Update: 2021-07-29
Focus on the new crown pneumonia epidemic
-
Four opportunities for auxiliary medication to switch to DTP!
Time of Update: 2021-07-29
In particular, some of the auxiliary drugs that have been used in hospitals for a long time and have been included in the state supervision in recent years, DTP pharmacy operators should pay attention to them when constructing the product structure .
-
2021 ASCO summary announced, Chinese pharmaceutical companies have a first look at drug data
Time of Update: 2021-07-29
This phase I clinical trial to be reported at this conference aims to evaluate the safety and preliminary anti-tumor activity of SHR-1701 in patients with refractory solid tumors .
-
PHEXCOM successfully completed the quality audit of Roquette
Time of Update: 2021-07-29
On July 6, PHEXCOM conducted an audit on Roquette Italy factory, a world-renowned pharmaceutical excipient company .
The medical excipients audited are pregelatinized modified starch .
The factory site quality audit was led by Dr.
-
Luoxin Pharmaceutical and HK inno.N of South Korea join hands again, aiming at the US$2 billion Chinese PPI injection market
Time of Update: 2021-07-29
N Corporation, we have once again worked together to develop the PPI injection market in China, further consolidating Luo Xin's leading position in the digestion field .
The cooperation between China and South Korea on tegoraxan injection products further demonstrates Luoxin Pharmaceutical's R&D and commercialization advantages in the gastrointestinal field .
-
The patent link system is on the string, under the trend of centralized procurement, will the domestic first generic drug market monopolize it?
Time of Update: 2021-07-29
In order to facilitate work connection, after the implementation of the early resolution mechanism for drug patent disputes, relevant patent information that has been registered as required during the test period will be disclosed after confirmation by the drug marketing license holder, as chemical generic drugs, traditional Chinese medicines with the same name, and biosimilars Information on the basis of the patent statement made by the drug applicant .
-
Academician Wu Tianyi: A medical emergency station has been built near the Rongbuk Monastery on Mount Everest
Time of Update: 2021-07-29
He said that after the Everest Medical First Aid Station near Rongbuk Monastery is put into use, it can provide services for about 120,000 climbers, scientific researchers, tourists, and business people a year as needed in the future .
-
Experts remind: high altitude exposure is easy to "sun" cataracts
Time of Update: 2021-07-29
Director Zhou Dan observed in clinical ophthalmology that the proportion of people in rural areas suffering from cataracts is significantly higher than that of urban populations; while in areas with relatively high altitudes and long-term high-intensity sunlight exposure, the prevalence of cataracts has risen sharply, especially Cataracts are more serious among the elderly in Qinghai-Tibet Plateau and Yunnan-Guizhou Plateau .
-
Children 3-17 years old can receive the same dose of new crown vaccine as adults
Time of Update: 2021-07-29
The results of the study showed that the immune response of children and adolescents was better than that of adults aged 18-59 and those aged 60 and over following the same immunization schedule with two doses of the medium-dose vaccine .
-
Health Commission: 18 newly diagnosed cases of new crown are all imported from abroad
Time of Update: 2021-07-29
As of 24:00 on July 1, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 436 confirmed cases (including 8 severe cases), 86,738 cured and discharged cases, and 4,636 deaths.
-
24 new confirmed cases on the 13th, 1 local case in Yunnan
Time of Update: 2021-07-29
As of 24:00 on July 13, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 501 confirmed cases (including 4 severe cases), 86,982 cured and discharged cases, and 4,636 deaths.
-
my country has 22 new crown vaccines in clinical trials
Time of Update: 2021-07-29
Yuan Lin, Director of the Department of Drug Supervision and Administration of the State Drug Administration, introduced at the State Council’s policy briefing on the 8th that the State Drug Administration has approved 22 new crown vaccines with 5 technical routes to enter clinical trials, and have conditions attached in accordance with laws and regulations.
-
Interleukin-6 receptor antagonist included in the new crown treatment plan
Time of Update: 2021-07-29
This is a class of drugs that have a life-saving effect on critically ill patients with new coronary disease, especially when used in combination with corticosteroids .
-
With a sales volume of US$1.86 billion in 2020, Roche enmetrastuzumab will soon be approved for new indications in China
Time of Update: 2021-07-29
As the first single-agent ADC approved for the treatment of HER2-positive metastatic breast cancer that has previously received trastuzumab and taxane chemotherapy (alone or in combination), Kadcyla's sales have increased year by year after its launch, reaching 1.
-
Health Commission: 18 new cases on the 28th, all imported from abroad
Time of Update: 2021-07-29
As of 24:00 on June 28, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 459 confirmed cases (including 12 severe cases), 86,676 cured and discharged cases, and 4,636 deaths.
-
Summary of NMPA's new anti-tumor drugs approved in June, domestic drugs ushered in a small outbreak
Time of Update: 2021-07-29
Drug name: Vidicuzumab (trade name: Aidixi, research code: RC48) R&D company: Rongchang Biological Indications: Gastric cancer (including adenocarcinoma of the gastroesophageal junction) On June 9th, NMPA announced that it had passed the priority review and approval procedure and conditionally approved the listing of Rongchang Bioinjection Vidicuzumab (trade name: Aidixi), which is suitable for HER2 patients who have received at least 2 types of systemic chemotherapy.
-
European Center for Disease Control: Delta strain will become the main European strain in August
Time of Update: 2021-07-29
The European Centers for Disease Control and Prevention pointed out in the risk assessment report that based on existing evidence, the delta strain is 40% to 60% higher than the alpha strain (the first B.
-
Health Commission: 23 new confirmed cases and 8 local cases are all in Yunnan
Time of Update: 2021-07-29
As of 24:00 on July 8, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 451 confirmed cases (including 4 severe cases), 86,902 cured and discharged cases, and 4,636 deaths.
-
CXO listing feast: after 4 arrows in a row, there are 7 more on the road
Time of Update: 2021-07-29
Basic situation of the four newly listed CXO companies Data source: prospectus Unit: 100 million yuan PE static (calculated based on 2020 net profit) Market value is based on the closing price at noon on June 28 From the above table, it has the following characteristics: 0 1 From the perspective of PE and market value, the capital market gives new high valuations .
-
Health Commission: 28 new confirmed cases and 5 local cases are in Yunnan
Time of Update: 2021-07-29
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 14 The latest situation of the novel coronavirus pneumonia as of 24:00 on July 14 The latest sit
